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Abstract - Although protein crystallization is a unit operation with potentially high separation factors, it has 
not been widely used in industry. Protein crystallization studies and practices have hitherto been largely 
limited to crystallography protocols. Knowledge of the behaviour of protein in solution would help to 
overcome empiric limitations in protein crystallisation. Thus, dissolution of porcine insulin and hen egg white 
lysozyme was studied and an unusual variation in solute concentration, with a concentration peak for short 
dissolution times, was verified. Polymorphic behaviour of protein in solution was observed, which altered 
physical properties such as solubility. 






Protein crystallisation has been little used as a 
downstream processing step in the bioprocess 
industry. Considering its great potential for 
achieving high purification and separation levels, 
one of the major obstacles to a wider use of 
crystallisation in this industry has been the lack of 
thermodynamic and kinetic data required for 
efficient crystallisation (Saikumar et al., 1998). 
Although until 2001 almost 400 biopharmaceuticals 
had either been approved or were in advanced 
clinical trials, insulin was the only product produced 
and administered in crystalline form (Shenoy et al., 
2001). Moreover, since powder is the most 
economical form for storing and transporting 
proteins and most protein is used in solution, a very 
good knowledge of protein dissolution and its 
implications is of paramount importance to the 
pharmaceutical industry. 
The very nature of proteins imposes several 
specificities to the study of their crystallisation. The 
main differences arise from the large size, low 
symmetry, large solvent content in protein crystals 
and low binding energies. Low binding energies 
cause the protein crystals to be soft and sensitive to 
small changes in external conditions. Proteins have a 
large number of potential attachment sites that are 
energetically almost as favourable as the small 
number of specific sites at which an ordered array 
(crystal) is formed (Kam et al., 1978).  
As a result the complexity of protein, there is a 
large probability that polymorphism or 
pseudopolymorphism will occur during protein 
crystallization. When several types of solids have 
exactly the same chemical composition but different 
crystal structures they are called polymorphs. In the 
case of protein crystals, the term “polymorph” rarely 
corresponds strictly to this definition. In some cases, 
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solvent molecules. In these cases, the most 
frequently used term is “pseudopolymorphism”, 
although some authors also use the term 
“solvatomorphism”. Polymorphic form is usually 
identified by the powder X-ray diffraction 
measurement (Yoshihashi et al., 2000). 
This article reports an abnormal behaviour of two 
well-known proteins (porcine insulin and hen egg 
white lysozyme) during their dissolution. After 
carefully studying the protein dissolution, evaluating 
the effects of pH and temperatures and analysing X-
ray diffraction responses, the polymorphic behaviour 
was found to be the most probable explanation for 





 The experimental procedure can be described as a 
sequence of actions taken as when determination of 
protein solubility revealed abnormal behaviour 









The porcine insulin (96.57% purity according to 
supplier) was gently donated by Biobrás, Brazil. The 
hen egg white lysozyme (purity of 99% according to 
supplier) was produced by Sigma, USA. Ultra-pure 
water was obtained by utilising Milli-Q from 
Millipore, USA. Anhydrous sodium acetate was 
produced by Merck, Germany and sodium chloride 
was purchased from Labsynth, Brazil and glacial 
acetic acid from Ecibra, Brazil. 
 
Dissolution by Magnetic Stirring 
 
In a 50 mL Erlenmeyer flask, 150 mg of insulin 
and 50 mL of 0.1 M sodium acetate solution with 7% 
NaCl were mixed, forming a suspension with an 
initial concentration of 3.0 mg/mL. The suspension 
was stirred with a magnetic bar in a controlled 
temperature bath. Periodically, a 1.0 mL sample was 
taken from the solution. The samples were 
centrifuged and the protein concentration of the 
resulting supernatant solution was measured.  
 
Dissolution by End-Over-End Rotation 
 
In Eppendorf flasks, suspensions of 4.0 to 7.0 mg 
of insulin and 1.0 mL of 0.1 M sodium acetate 
solution with 7% NaCl were mixed by end-over-end 
rotation (at ca. 12.5 rpm in a 20 cm diameter rotor) 
in a controlled-temperature environment. 
Periodically, two or three flasks were collected and 
centrifuged and absorbance of the resulting 
supernatant solution was measured. The same 
procedure was followed for lysozyme studies with 
18 to 22 mg of protein and 1.0 mL of 0.05 M sodium 
acetate solution with 10% NaCl. The use of different 
quantities of insulin and lysozyme is due to 
observance of complete dissolution with less protein 
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Determination of Total Protein Concentration 
 
Total soluble protein concentration was 
determined by measuring absorption at 280 and 320 
nm in a Beckman spectrophotometer DU650 (USA). 
The differences between these measurements were 
used in the calculate concentration in order to avoid 
errors due to the occasional presence of particulate 
material in solution (Gehle and Schügerl, 1984). 
 
Test for Insulin Fibrillation  
 
The possibility of insulin fibrillation was verified 
by an assay similar to the end-over-end rotation 
dissolution. A 16.5 mL glass tube with 15 glass 
beads (ca. 2 mm diameter) was filled with 50 mg of 
insulin. The headspace was filled up with 0.1 M 
sodium acetate solution with 7% NaCl. In this way, 
the hydrophobic interfaces were eliminated, except for 
the entrapped air in the pores of the insulin particles. 
This virtually eliminated the possibility of fibrillation 




Insulin and lysozyme suspensions (3.0 and 20 
mg/mL, respectively) were prepared in 0.1 M with 7 % 
NaCl and 0.05 M with 10 of NaCl sodium acetate 
solutions, respectively. The suspensions were stirred 
magnetically up to 48 h at ambient temperature and 
filtered with number 10 Whattman paper. The 
retained solids were dried for 12 h at ambient 
temperature. These solids were referred to as 
processed particles and used in a second dissolution 




X-ray diffraction analyses were done with XRD 
6000 equipment (Shimadzu, Japan) utilising CuΚα 
radiation; scanning tension and current were 40 kV 
and 30 mA, and sample rotation was 20 rpm. The 
angles (2θ) varied from 5 to 60° at 2° per minute. 
 
 
RESULTS AND DISCUSSION 
 
It is expected that the liquid-phase concentration 
of a dissolving solid increases with time until a 
plateau is reached, with this concentration plateau 
representing the solid solubility under a given 
condition. However, for insulin dissolution the 
behaviour observed was different as insulin 
concentration decreased after reaching a maximum 
(Figure 2). We addressed whether this behaviour 
would take place at different pH’s values (pH 3.2, 
5.5, and 6.6). These values were chosen to evaluate 
the effect of the net surface charge of the molecules 
and of the different ways in which insulin molecules 
combine in solution. At pH 3.2 insulin is positively 
charged and is found predominantly as a 
combination of monomers or dimmers. At pH 5.5 
(the isoelectric point of insulin) the net surface 
charge is null; and at pH 6.6 the molecule is 
negatively charged and predominantly combines as 








Figure 2: Dissolution of porcine insulin in 0.1 M sodium acetate solution with 7% NaCl at 25°C and       
different pH levels by magnetic stirring. The symbols ¨, ¡, and ?  correspond to the mean values of                       
a triplicate at pH’s values of 3.2, 5.5, and 6.6, respectively. Figure (a) is the original figure and (b)                      
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The same dissolution behaviour was observed 
keeping the pH value constant at 5.5 and varying the 
temperature (Figure 3).  
 Taking the solubility of insulin as the average 
concentration on the plateau (time longer than 1500 
min), its values for these three pH and temperatures 
levels were determined (Table 1). 
The variation in solubility with pH at 25°C was 
the opposite of the behaviour expected, since at the 
isoelectric point protein solubility is usually at its 
lowest value. However, at pH 5.5 was observed a 
local maximum value of solubility. 
The profile observed for all conditions studied (a 
sharp peak for short periods of time, followed by a 
decrease in concentration to an equilibrium value) 
suggests the likely occurrence of some change in 
crystal structure or in crystallinity. In order to 
verify this hypothesis, dissolution profiles for 
original and processed insulin particles were 
determined (Figure 4).  
Dissolution of processed insulin at pH 3.2 and pH 
5.5 showed the expected behaviour: a monotonic 
increase in concentration tending asymptotically 
towards equilibrium, which suggests a structural 
rearrangement of insulin particles during dissolution. 
At pH 6.6, the unexpected behaviour of dissolution 
was obtained, even after insulin had been processed 
twice under this condition. Furthermore, at pH 3.2, 
the concentration peak was less accentuated than for 
the other pH’s. A possible explanation for this is that 
the relative quantities of hexamers in solution in the 
suspension at time zero may play a role in this 
phenomenon. According to Blundell et al (1972), at 
pH 7.0 almost all insulin in solution is combined as 
hexamers, and at pH 2.0 the dimmers are the species 
with the largest population. So, it is expected that at 
pH 6.6, insulin in solution is preferentially combined 
as hexamers, while at pH 3.2, insulin monomers and 
dimmers are predominant. At pH 5.5, an 








Figure 3: Dissolution of porcine insulin in 0.1 M sodium acetate buffer solution with 7% NaCl at pH 5.50          
and different temperatures by magnetic stirring. The symbols ¨, ¡, and ?  correspond to the triplicates at 
temperatures of 15, 25, and 35oC, respectively. Figure (a) is the original figure and (b) is a zoom of the 
concentration peaks. The dashed lines in (a) represent equilibrium values. 
 
 
Table 1: Solubility of porcine insulin as a function of pH at 25°C in 0.1 M  
sodium acetate solution with 7% NaCl. 
 
Temperature pH C* (mg/mL)a 
25 3.2 0.1209 ± 0.0058 
15 5.5 0.9181 ± 0.2049 
25 5.5 0.6260 ± 0.0250 
35 5.5 0.3013 ± 0.0946 
25 6.6 0.1864 ± 0.0147 
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Figure 4: Comparison between dissolution profiles of original and processed samples of insulin in  
0.1 M  acetate solution with 7% NaCl at pH 3.2 (a), pH 5.5 (b), and pH 6.6 (c). The symbols ¨, ¡, r                   
correspond to original sample, processed sample, and sample processed twice, respectively. 
 
 
X-ray diffraction analyses of original and 
processed particles were done in order to evaluate 
occasional structural changes at the crystal level 
(Figure 5). Despite the low crystallinity of all samples, 
little difference between the spectra of the original and 
the processed insulin particles could be detected: the 
presence of well-defined peaks for the processed 
samples and a relative change in the halo from 5° to 
25°. These peaks were sodium chloride peaks (found in 
the dissolving systems at a concentration of 7%). Their 
intensity did not vary under the different processing 
conditions, suggesting that this salt may only be found 
in void spaces. Changes in the halo from 5° to 25° 
suggest that processing had little effect on the low 
degree of cristallinity. 
By comparing dissolution experiments and x-ray 
diffraction analyses, it may be inferred that a 
rearrangement of the structure occurs during 
dissolution as well as probably a change in the 
degree of solvation and that rearrangement is not 
affected by the processing conditions. 
Furthermore, in order to guarantee that the 
observed changes are not due to degradation of the 
protein, the possibility of insulin fibrillation was 
tested. Fibrillation is the most probable mechanism 
of insulin degradation, catalysed by hydrophobic 
surfaces under high shear (agitation) conditions. 
Figure 6 eliminates the possibility of fibrillation as 
under conditions in which fibrillation does not occur, 
a concentration peak was also observed. 
Lysozyme dissolution was also studied to 
corroborate the results observed with insulin. 
Nevertheless, the amount of available lysozyme was 
much lower, which called for changes in 
methodology. Eppendorf flasks were used in the 
dissolution assays. Therefore the time necessary to 
reach equilibrium was longer for lysozyme due to the 
less vigorous mixing besides the specific kinetics of 
dissolution of this protein. As equilibrium data for 
lysozyme are quite common (Howard et al., 1988; 
Forsythe and Pusey, 1996), obtaining solubility data 
was not a goal, except for pH 3.5. 
Because the comparison between insulin and 
lysozyme results was always intended, the same 
solvent system was used for lysosyme. This placed a 
limitation on the attainable pH range, thereby 
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Figure 5: X-ray diffraction analysis of insulin samples: original (a) and processed at  
pH 3.2 (b), pH 5.5 (c), and pH 6.6 (d). Scanning tension, current, and velocity  




Figure 6: Dissolution profile of porcine insulin in 0.1 M sodium acetate buffer solution with 7%  
NaCl at pH 5.50 in a glass tube rotated end-over-end with glass beads in an almost air-free  
environment – conditions under which possibility of fibrillation is very remote. 
 
 
The unusual behaviour – already observed in 
insulin – was repeated with lysozyme (Figure 7).  
Protein concentration peaks during dissolution 
were also observed for lysozyme. Dissolution of 
processed lysozyme sample (Figure 8) and 
comparison of X-ray diffraction analysis of original 
and processed lysozyme (Figure 9) were done to 
verify the polymorphic behaviour, as the case of 
insulin. 
The kinetics of dissolution of processed lysozyme 
at pH 3.5 and pH 4.5 (Figure 8) as well as X-ray 
diffraction analysis (Figure 9) of original and 
processed samples of lysozyme at different pH’s 
suggest a change in crystalline structure or in degree 
of crystallinity during dissolution of original 
particles as in the case of insulin. For lysozyme, 
processing conditions affected the X-ray spectra (the 
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peaks were detected at different intensities), 
suggesting that the salt was in someway associated 
with the protein molecules and not only included in 
void spaces, or else the void spaces could vary with 
processing conditions and accumulate different 
quantities of salt. However, the cause of the 
difference in peak intensity cannot be assured due to 
limitations of the X-ray technique. 
The polymorphic behaviour of the proteins 
studied provides a plausible explanation for the 
concentration peak followed by equilibrium in the 
dissolution kinetics, since polymorphism is the 
existence of different crystalline structures for the 
same chemical species that can have different 
physicochemical properties. Moreover, polymorphism 
should explain why the dependence of insulin 
solubility on pH is the opposite of what is expected. 
Different pH’s values would show solubility of 
different polymorphs, and not the variation in 
solubility of one single entity.  
Regarding the low crystallinity observed in all 
conditions studied, Pikal et al. (1978) call attention 
to the importance of polymorphism in 
pharmaceutical systems and claim that partial 
crystallinity is a special case of polymorphism, 
which may have significant effects on dissolution 
rate and on chemical stability. Even a small quantity 
of amorphous phase in a different crystalline sample 
is sufficient to alter measurably the physical and 








Figure 7: Dissolution kinetics of lysozyme in 0.05 M acetate buffer with  








Figure 8: Dissolution kinetics of original and processed lysozyme in 0.05 M acetate buffer  
with 10 % NaCl at 25°C and pH 4.5 (a) and pH 3.5 (b). Symbols ¨ and ¡  
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Figure 9: X-ray diffraction analysis of lysozyme: original sample (a), sample processed at pH 3.5 (b), and 
sample processed at pH 4.5 (c). Scanning tension, current, and velocity were 40 kV,  





The unique structure of protein molecules gives 
rise to the unique characteristics of their crystals. 
Proteins crystals have a much larger void volume 
and lower crystallinity than crystals of small 
molecules. Besides, their complex structure is 
heavily dependent on environment conditions, 
especially pH. Therefore, the dependence on pH of 
the behaviour of crystals in solution seems natural. 
This study showed the unique behaviour of protein 
crystals in solution. Insulin and lysozyme showed 
polymorphic behaviour during dissolution. This 
polymorphic behaviour was strongly dependent on 
pH for both molecules. One of the most important 
consequences of polymorphism is alteration of 
physical properties. This study shows that 
polymorphic behaviour strongly alters the solubility of 
insulin (solubility of lysozyme was not studied). 
Another important consequence is the variation in 
concentration of total soluble protein with time. As 
applications for protein have usually been 
pharmaceutical (as insulin for example) bioavailability 
is an important factor to be considered. 
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